FDA Inspection 1165879 — Children's Hospital of Alabama Blood Bank
The FDA completed an inspection of Children's Hospital of Alabama Blood Bank on March 25, 2022 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Birmingham, AL (United States)